BioCentury
ARTICLE | Company News

Cardax, BASF deal

December 11, 2006 8:00 AM UTC

BF will exclusively manufacture a derivative of astaxanthin, an intermediate used to make Cardax's Xancor, which is in preclinical testing to treat cardiovascular inflammatory disease. BF also receive...